1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with sebacic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amuzie, C; Bedja, D; Bhattacharya, R; Chatterjee, S; Foss, CA; Mishra, S; Pomper, MG; Yarema, KJ | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and sebacic acid
Article | Year |
---|---|
Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Capsules; Cardiomegaly; Cholesterol, Dietary; Decanoic Acids; Delayed-Action Preparations; Dicarboxylic Acids; Diet, Atherogenic; Drug Evaluation, Preclinical; Heart Ventricles; Inactivation, Metabolic; Iodine Radioisotopes; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Morpholines; Nanoparticles; Polyethylene Glycols; Tissue Distribution; Vascular Stiffness | 2015 |